Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Prostap SR DCS 3.75mg powder and solvent for prolonged-release suspension for injection pre-filled syringes (Takeda UK Ltd) |
| BNF code | 0803042N0BBACAC |
| Virtual Medicinal Product | Leuprorelin 3.75mg powder and solvent for prolonged-release suspension for injection pre-filled syringes |
| Name | Prostap SR DCS 3.75mg powder and solvent for prolonged-release suspension for injection pre-filled syringes |
| Abbreviated name | Prostap SR DCS 3.75mg inj pre-filled syringes |
| Date of name applicability | 1 Dec 2024 |
| Previous name | Prostap SR DCS 3.75mg powder and solvent for suspension for injection pre-filled syringes |
| Supplier | Takeda UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Subcutaneous |
| Licensed Route | |
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Prostap SR DCS 3.75mg powder and solvent for prolonged-release suspension for injection pre-filled syringes (Takeda UK Ltd) 1 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_1.2.0_20250113000001, imported on 14th January 2025 at 04:06:47.